T1	Participants 470 677	Patients scheduled to undergo ESD for early gastric cancer or adenoma were randomly assigned to sedation with midazolam or propofol, and consciousness level was evaluated by bispectral index (BIS) monitoring
T2	Participants 983 1065	June 2008 through June 2009, we enrolled 178 patients (90 midazolam, 88 propofol).
